The Venture Codex Logo

The Venture Codex

Overview

Develops novel oral inhibitors for prostate and hormonally-driven cancers.

Total Raised

$28 M

Rounds

1

Links

Verticals

Biotechnology
Health Care
Medical
Pharmaceutical

Investment History

  1. Series D

    Apr 2015

    $28M

Team